Vol 80, No 3 (2022)
Short communication
Published online: 2022-01-13

open access

Page views 4911
Article views/downloads 496
Get Citation

Connect on Social Media

Connect on Social Media

Prevalence of heart rhythm disorders in patients with end-stage heart failure referred to qualification for heart transplantation

Adam Wojtaszczyk12, Mariusz Gąsior1, Bożena Szyguła-Jurkiewicz1, Mateusz Tajstra1
Pubmed: 35023568
Kardiol Pol 2022;80(3):339-341.

Abstract

Not available

References

  1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
  2. Andrew J, Macdonald P. Latest developments in heart transplantation: a review. Clin Ther. 2015; 37(10): 2234–2241.
  3. Paluszkiewicz L, Kukulski T, Zembala M, et al. The role of long-term mechanical circulatory support in the treatment of end-stage heart failure. Kardiol Pol. 2019; 77(3): 331–340.
  4. AlTurki A, Proietti R, Dawas A, et al. Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2019; 19(1): 18.
  5. Pedersen CT, Kay GN, Kalman J, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace. 2014; 16(9): 1257–1283.
  6. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009; 119(18): 2516–2525.
  7. Ziff OJ, Carter PR, McGowan J, et al. The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry. Int J Cardiol. 2018; 252: 117–121.
  8. Wijesurendra RS, Casadei B. Atrial fibrillation: effects beyond the atrium? Cardiovasc Res. 2015; 105(3): 238–247.
  9. Range FT, Schäfers M, Acil T, et al. Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. Eur Heart J. 2007; 28(18): 2223–2230.
  10. Freestone B, Chong AY, Nuttall S, et al. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. Thromb Res. 2008; 122(1): 85–90.
  11. Lim HS, Willoughby SR, Schultz C, et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol. 2013; 61(8): 852–860.
  12. Gadula-Gacek E, Tajstra M, Niedziela J, et al. Characteristics and Outcomes in Patients With Electrical Storm. Am J Cardiol. 2019; 123(10): 1637–1642.
  13. Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013; 34(46): 3547–3556.
  14. Gąsior M, Pyka Ł, Gorol J, et al. COnteMporary Modalities In Treatment of Heart Failure: a report from the COMMIT-HF registry. Kardiol Pol. 2016; 74(6): 523–528.
  15. Tajstra M, Sokal A, Gadula-Gacek E, et al. Remote Supervision to Decrease Hospitalization Rate (RESULT) study in patients with implanted cardioverter-defibrillator. Europace. 2020; 22(5): 769–776.



Polish Heart Journal (Kardiologia Polska)